Novel Strategies Show Winning Potential in Ovarian Cancer

(MedPage Today) -- TAMPA, Fla. -- Adding a T-cell primer to a PD-1 inhibitor led to objective responses in a third of patients with recurrent platinum-refractory/resistant ovarian cancer enrolled in a small preliminary study. Eight of 24 patients...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news